Re­call re­port: Fre­se­nius Kabi yanks in­flam­ma­to­ry med Ke­toro­lac af­ter find­ing par­tic­u­lates in vials

The FDA on Fri­day an­nounced that Fre­se­nius Kabi USA, based in Illi­nois, vol­un­tar­i­ly re­called a sin­gle lot of Ke­toro­lac Tromethamine …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.